Skip to main content

Advertisement

Log in

Continuous positive airway pressure device-based automated detection of obstructive sleep apnea compared to standard laboratory polysomnography

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Purpose

Obstructive sleep apnea (OSA) is a common health problem that affects more than 2–4% of the US population. Polysomnography (PSG) is the gold standard for diagnosing OSA. PSG is, however, expensive, time-consuming, and not always readily accessible. Hence, alternative diagnostic methods such as home-based testing have been evaluated. We studied the ability of the REMstar Pro (RSP2, a brand of continuous positive airway pressure (CPAP) device) to identify abnormal breathing events in subjects with OSA and compared this with breathing events simultaneously determined by laboratory-based PSG.

Methods

We evaluated 10 subjects previously diagnosed with OSA (apnea hypopnea index (AHI) > 15, known therapeutic level of CPAP). Subjects underwent attended PSG using the REMstar Pro M series machine and their prescribed interface/mask type. The first 3 h of the study were conducted using a subtherapeutic CPAP (4 cm H2O). The last 3 h or remaining portion of the PSG was completed using the previously determined therapeutic CPAP. Comparison of respiratory events detected by PSG vs the RSP2 was performed.

Results

Subjects included four men and six women, aged 32 to 57 years and with a body mass index ranging from 29.5–66.4. The baseline AHI ranged from 18.3–93.1, with the AHI at therapeutic CPAP ranging from 0–3. Apnea counts at baseline and at therapeutic CPAP by manually scored PSG and REMstar were not significantly different (mean at subtherapeutic 11.7 vs 12.5, p = 0.76; median at therapeutic CPAP 2.0 vs 4.5, p = 0.15). Hypopnea counts at baseline and at effective CPAP by PSG and REMstar were not significantly different (mean at subtherapeutic 38.1 vs. 40.9, p = 0.72; median at therapeutic CPAP 5.0 vs. 2.5, p = 0.34). The correlation coefficient of REMstar and PSG for apnea and hypopnea was significant in subtherapeutic phase only (apnea r = 0.78, p = 0.007; hypopnea r = 0.76, p = 0.01). Agreement between the two methods declined for hypopnea detection at therapeutic CPAP.

Conclusions

The monitoring of residual sleep-disordered breathing on treatment, in addition to adherence, is an important objective therapeutic target in OSA. The REMstar Pro detects sleep-disordered breathing events similar to that of a manually scored PSG—for apnea but not for hypopnea—and merits further investigation as a device to determine disease severity and treatment efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230–1235

    Article  CAS  PubMed  Google Scholar 

  2. Day R, Gerhardstein R, Lumley A, Roth T, Rosenthal L (1999) The behavioral morbidity of obstructive sleep apnea. Prog Cardiovasc Dis 41(5):341–354

    Article  CAS  PubMed  Google Scholar 

  3. D’Ambrosio C, Bowman T, Mohsenin V (1999) Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure—a prospective study. Chest 115(1):123–129

    Article  PubMed  Google Scholar 

  4. Alghanim N, Comondore VR, Fleetham J, Marra CA, Ayas NT (2008) The economic impact of obstructive sleep apnea. Lung 186(1):7–12

    Article  PubMed  Google Scholar 

  5. Quan SF, Gersh BJ (2004) Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation 109(8):951–957

    Article  PubMed  Google Scholar 

  6. Nieto FJ, Young TB, Lind BK et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. Jama 283(14):1829–1836

    Article  CAS  PubMed  Google Scholar 

  7. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034–2041

    Article  CAS  PubMed  Google Scholar 

  8. Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR (2008) Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 31(8):1079–1085

    PubMed  Google Scholar 

  9. Chesson AL Jr, Berry RB, Pack A (2003) Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep 26(7):907–913

    PubMed  Google Scholar 

  10. Santamaria J, Iranzo A, Ma Montserrat J, de Pablo J (2007) Persistent sleepiness in CPAP treated obstructive sleep apnea patients: evaluation and treatment. Sleep Med Rev 11(3):195–207

    Article  PubMed  Google Scholar 

  11. Stradling JR, Smith D, Crosby J (2007) Post-CPAP sleepiness—a specific syndrome? J Sleep Res 16(4):436–438

    Article  PubMed  Google Scholar 

  12. Baltzan MA, Kassissia I, Elkholi O, Palayew M, Dabrusin R, Wolkove N (2006) Prevalence of persistent sleep apnea in patients treated with continuous positive airway pressure. Sleep 29(4):557–563

    PubMed  Google Scholar 

  13. Portier F, Portmann A, Czernichow P et al (2000) Evaluation of home versus laboratory polysomnography in the diagnosis of sleep apnea syndrome. Am J Respir Crit Care Med 162(3 Pt 1):814–818

    CAS  PubMed  Google Scholar 

  14. Iber C, Ancoli-Israel S, Chesson AL, Quan SF (2007) The AASM manual for the scoring of sleep and associated events. American Academy of Sleep Medicine, Westchester

    Google Scholar 

  15. Kushida CA, Chediak A, Berry RB et al (2008) Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 4(2):157–171

    PubMed  Google Scholar 

  16. Ikeda Y KT, Takaya H, Maeno K, Kawana F, Ishiwata S, Narui K (2008) Validation of breathing event detection of the REMstar auto M-series compared to clinical polysomnography ATS international conference abstracts, A212

Download references

Acknowledgment

The authors would like to thank the clinical and research staff of the Sleep Science Center and the Center for Narcolepsy, Sleep and Health Research at the University of Illinois at Chicago.

Disclosure

This study was funded by Respironics, Inc., Murrysville, PA, USA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bharati Prasad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prasad, B., Carley, D.W. & Herdegen, J.J. Continuous positive airway pressure device-based automated detection of obstructive sleep apnea compared to standard laboratory polysomnography. Sleep Breath 14, 101–107 (2010). https://doi.org/10.1007/s11325-009-0285-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-009-0285-z

Keywords

Navigation